Published in Stroke on November 13, 2008
The ARUBA trial: current status, future hopes. Stroke (2010) 1.22
Endovascular treatment accounts for a change in brain arteriovenous malformation natural history risk. Interv Neuroradiol (2010) 1.01
Untreated brain arteriovenous malformation: patient-level meta-analysis of hemorrhage predictors. Neurology (2014) 0.94
Noncontrast dynamic 3D intracranial MR angiography using pseudo-continuous arterial spin labeling (PCASL) and accelerated 3D radial acquisition. J Magn Reson Imaging (2013) 0.90
Embolization and radiosurgery for arteriovenous malformations. Surg Neurol Int (2012) 0.89
Safety and efficacy using a detachable tip microcatheter in the embolization of pediatric arteriovenous malformations. Childs Nerv Syst (2014) 0.88
Developmental and pathological angiogenesis in the central nervous system. Cell Mol Life Sci (2014) 0.86
Hemorrhage rates and risk factors in the natural history course of brain arteriovenous malformations. Transl Stroke Res (2014) 0.86
Risk of cerebral arteriovenous malformation rupture during pregnancy and puerperium. Neurology (2014) 0.85
Bleeding source identification and treatment in brain arteriovenous malformations. Interv Neuroradiol (2011) 0.85
Common variants on 9p21.3 are associated with brain arteriovenous malformations with accompanying arterial aneurysms. J Neurol Neurosurg Psychiatry (2014) 0.85
Transvenous embolization of a ruptured deep cerebral arteriovenous malformation. A technical note. Interv Neuroradiol (2013) 0.84
A prospective follow-up study of the association of radiation exposure with fatal and non-fatal stroke among atomic bomb survivors in Hiroshima and Nagasaki (1980-2003). BMJ Open (2012) 0.84
Clinical features and endovascular treatment of intracranial arteriovenous malformations in pediatric patients. Childs Nerv Syst (2013) 0.83
Non-invasive imaging of intracranial pediatric vascular lesions. Childs Nerv Syst (2010) 0.82
Brain arteriovenous malformation diagnosis: value of time-resolved contrast-enhanced MR angiography at 3.0T compared to DSA. Neuroradiology (2012) 0.81
Imaging of small animal peripheral artery disease models: recent advancements and translational potential. Int J Mol Sci (2015) 0.79
The role of microsurgical resection and radiosurgery for cerebral arteriovenous malformations. Methodist Debakey Cardiovasc J (2015) 0.77
Treatment of Brain AVMs (TOBAS): study protocol for a pragmatic randomized controlled trial. Trials (2015) 0.76
Cerebral arteriovenous malformations: evaluation and management. ScientificWorldJournal (2014) 0.76
Proton beam stereotactic radiosurgery for pediatric cerebral arteriovenous malformations. Neurosurgery (2014) 0.76
Multimodal angiographic assessment of cerebral arteriovenous malformations: a pilot study. J Neurointerv Surg (2014) 0.75
Treatment of a giant arteriovenous malformation associated with intracranial aneurysm rupture during pregnancy: A case report. Exp Ther Med (2016) 0.75
Ruptured Arteriovenous Malformation Presenting with Kernohan's Notch. Case Rep Neurol Med (2015) 0.75
Long-term control of large pontine arteriovenous malformation using gamma knife therapy: a review with illustrative case. Brain Behav (2013) 0.75
Diagnosis and evaluation of intracranial arteriovenous malformations. Surg Neurol Int (2015) 0.75
Experimental study of temperature-sensitive chitosan/β-glycerophosphate embolic material in embolizing the basicranial rete mirabile in swines. Exp Ther Med (2015) 0.75
Microsurgery for intracranial arteriovenous malformation: Long-term outcomes in 445 patients. PLoS One (2017) 0.75
Dormant micro arteriovenous malformations lead to recurrent cerebral haemorrhage. Springerplus (2016) 0.75
Role of trauma and infection in childhood hemorrhagic stroke due to vascular lesions. Neurology (2013) 0.75
Curative glubran 2 embolization of cerebral arteriovenous malformations patient selection and initial results. Interv Neuroradiol (2014) 0.75
Case Report: Microsurgical excision of grade 5 cerebral AVM. F1000Res (2015) 0.75
Less can be more: Targeted embolization of aneurysms associated with arteriovenous malformations unsuitable for surgical resection. Interv Neuroradiol (2016) 0.75
The relationship of cortical folding and brain arteriovenous malformations. Neurovasc Imaging (2016) 0.75
Trends in the management of intracranial vascular malformations in the USA from 2000 to 2007. Stroke Res Treat (2012) 0.75
Ruptured brain arteriovenous malformations associated with aneurysms: safety and efficacy of selective embolization in the acute phase of hemorrhage. Neuroradiology (2014) 0.75
Targeted Embolization of Aneurysms Associated With Brain Arteriovenous Malformations at High Risk for Surgical Resection: A Case-Control Study. Neurosurgery (2017) 0.75
Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med (2015) 12.70
A key role for TRPM7 channels in anoxic neuronal death. Cell (2003) 4.46
Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain. Nature (2012) 4.04
Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions. Science (2002) 3.98
NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J Neurosci (2007) 3.44
Clinical course of cranial dural arteriovenous fistulas with long-term persistent cortical venous reflux. Stroke (2002) 2.93
Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch (2010) 2.83
Calcium, ischemia and excitotoxicity. Cell Calcium (2010) 2.38
Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol (2012) 2.34
Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium (2003) 2.21
Benign cranial dural arteriovenous fistulas: outcome of conservative management based on the natural history of the lesion. J Neurosurg (2002) 2.19
Intracranial aneurysms: from vessel wall pathology to therapeutic approach. Nat Rev Neurol (2011) 1.77
Suppression of hippocampal TRPM7 protein prevents delayed neuronal death in brain ischemia. Nat Neurosci (2009) 1.75
Steal physiology is spatially associated with cortical thinning. J Neurol Neurosurg Psychiatry (2010) 1.73
Inhibition of caspase-mediated apoptosis by peroxynitrite in traumatic brain injury. J Neurosci (2006) 1.63
PDZ protein interactions underlying NMDA receptor-mediated excitotoxicity and neuroprotection by PSD-95 inhibitors. J Neurosci (2007) 1.62
Beyond NMDA and AMPA glutamate receptors: emerging mechanisms for ionic imbalance and cell death in stroke. Trends Pharmacol Sci (2008) 1.62
Specific targeting of pro-death NMDA receptor signals with differing reliance on the NR2B PDZ ligand. J Neurosci (2008) 1.58
Impaired peri-nidal cerebrovascular reserve in seizure patients with brain arteriovenous malformations. Brain (2010) 1.56
Treatment of intracranial aneurysms with hydrogel coated expandable coils. Can J Neurol Sci (2007) 1.55
Direct imaging of the distal dural ring and paraclinoid internal carotid artery aneurysms with high-resolution T2 turbo-spin echo technique at 3-T magnetic resonance imaging. Neurosurgery (2009) 1.53
Wall enhancement, edema, and hydrocephalus after endovascular coil occlusion of intradural cerebral aneurysms. J Neurosurg (2008) 1.51
Surgical activity of first-year Canadian neurosurgical residents. Can J Neurol Sci (2010) 1.41
Aneurysmal wall enhancement and perianeurysmal edema after endovascular treatment of unruptured cerebral aneurysms. Neuroradiology (2014) 1.39
Priority setting in neurosurgery as exemplified by an everyday challenge. Can J Neurol Sci (2013) 1.39
Proximity to the treating centre and outcomes following subarachnoid hemorrhage. Can J Neurol Sci (2011) 1.38
Angioarchitectural factors present in brain arteriovenous malformations associated with hemorrhagic presentation. Stroke (2002) 1.38
TRPM7 channels in hippocampal neurons detect levels of extracellular divalent cations. Proc Natl Acad Sci U S A (2007) 1.37
Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat. Stroke (2008) 1.31
Multidisciplinary management of spinal dural arteriovenous fistulas: clinical presentation and long-term follow-up in 49 patients. Stroke (2002) 1.31
Cerebral vascular abnormalities in a murine model of hereditary hemorrhagic telangiectasia. Stroke (2003) 1.25
Increased phosphorylation and redistribution of NMDA receptors between synaptic lipid rafts and post-synaptic densities following transient global ischemia in the rat brain. J Neurochem (2005) 1.24
Intracranial cavernous malformations. Neuroimaging Clin N Am (2003) 1.24
Preoperative and postoperative mapping of cerebrovascular reactivity in moyamoya disease by using blood oxygen level-dependent magnetic resonance imaging. J Neurosurg (2005) 1.23
TRPMs and neuronal cell death. Pflugers Arch (2005) 1.19
Ca2+-dependent induction of TRPM2 currents in hippocampal neurons. J Physiol (2009) 1.19
Intracranial venous system: gadolinium-enhanced three-dimensional MR venography with auto-triggered elliptic centric-ordered sequence--initial experience. Radiology (2003) 1.17
Vulnerability of central neurons to secondary insults after in vitro mechanical stretch. J Neurosci (2004) 1.15
Management of patients with brain arteriovenous malformations. Eur J Radiol (2003) 1.15
A discriminative prediction model of neurological outcome for patients undergoing surgery of brain arteriovenous malformations. Stroke (2006) 1.12
Diagnostic characteristics and management of intracranial aneurysms in children. Neuroimaging Clin N Am (2007) 1.11
Vessel wall MRI to differentiate between reversible cerebral vasoconstriction syndrome and central nervous system vasculitis: preliminary results. Stroke (2011) 1.11
Molecular mechanisms underlying specificity of excitotoxic signaling in neurons. Curr Mol Med (2004) 1.11
Microstent-assisted coiling for wide-necked intracranial aneurysms. Can J Neurol Sci (2005) 1.10
Three-dimensional in vivo modeling of vestibular schwannomas and surrounding cranial nerves with diffusion imaging tractography. Neurosurgery (2011) 1.10
Spinal dural arteriovenous fistula localization with a technique of first-pass gadolinium-enhanced MR angiography: initial experience. Radiology (2002) 1.09
Involvement of caspase-6 and caspase-8 in neuronal apoptosis and the regenerative failure of injured retinal ganglion cells. J Neurosci (2011) 1.09
Nonhuman primate models of stroke for translational neuroprotection research. Neurotherapeutics (2012) 1.05
Impaired cerebrovascular reactivity with steal phenomenon is associated with increased diffusion in white matter of patients with Moyamoya disease. Stroke (2010) 1.04
A translational paradigm for the preclinical evaluation of the stroke neuroprotectant Tat-NR2B9c in gyrencephalic nonhuman primates. Sci Transl Med (2012) 1.02
Novel treatment of excitotoxicity: targeted disruption of intracellular signalling from glutamate receptors. Biochem Pharmacol (2003) 1.02
Selective disconnection of cortical venous reflux as treatment for cranial dural arteriovenous fistulas. J Neurosurg (2004) 1.01
Impact of extracranial-intracranial bypass on cerebrovascular reactivity and clinical outcome in patients with symptomatic moyamoya vasculopathy. Stroke (2011) 0.99
Cellular schwannoma of the abducens nerve: case report and review of the literature. Clin Neurol Neurosurg (2009) 0.98
Multiplicity of dural arteriovenous fistulas. J Neurosurg (2002) 0.98
Neuroprotection by freezing ischemic penumbra evolution without cerebral blood flow augmentation with a postsynaptic density-95 protein inhibitor. Stroke (2011) 0.98
Large and deep brain arteriovenous malformations are associated with risk of future hemorrhage. Stroke (2002) 0.96
Extraventricular anaplastic ependymoma with metastasis to scalp and neck. J Neurooncol (2011) 0.96
Surveillance of intracranial aneurysms treated with detachable coils: a comparison of MRA techniques. Neuroradiology (2005) 0.95
TRPM7 and ischemic CNS injury. Neuroscientist (2005) 0.95
Impact of individual intracranial arterial aneurysm morphology on initial obliteration and recurrence rates of endovascular treatments: a multivariate analysis. J Neurosurg (2010) 0.93
Cerebral cavernous malformations and pregnancy: hemorrhage risk and influence on obstetrical management. Neurosurgery (2012) 0.93
Outcome and cost of aneurysmal subarachnoid hemorrhage. Neurosurg Clin N Am (2010) 0.91
Clinical and angiographic long-term follow-up of completely coiled intracranial aneurysms using endovascular technique. J Neurosurg (2010) 0.91
Shunt-dependent hydrocephalus after aneurysmal subarachnoid hemorrhage: incidence, predictors, and revision rates. Clinical article. J Neurosurg (2009) 0.91
Surgical revascularization reverses cerebral cortical thinning in patients with severe cerebrovascular steno-occlusive disease. Stroke (2011) 0.91
Symptomatic enlargement of an occluded giant carotido-ophthalmic aneurysm after endovascular treatment: the vasa vasorum theory. Acta Neurochir (Wien) (2009) 0.90
Severely impaired cerebrovascular reserve in patients with cerebral proliferative angiopathy. J Neurosurg Pediatr (2011) 0.90
Analysis of cost related to clinical and angiographic outcomes of aneurysm patients enrolled in the international subarachnoid aneurysm trial in a North American setting. Neurosurgery (2005) 0.89
The contribution of imaging in diagnosis, preoperative assessment, and follow-up of moyamoya disease: a review. Neurosurg Focus (2009) 0.88
Intracranial dural arteriovenous shunts: transarterial glue embolization--experience in 115 consecutive patients. Radiology (2010) 0.88
Enhanced vulnerability to NMDA toxicity in sublethal traumatic neuronal injury in vitro. J Neurotrauma (2003) 0.88
Venous congestive encephalopathy related to cranial dural arteriovenous fistulas. Neuroimaging Clin N Am (2003) 0.87
Sacral intradural arteriovenous fistula treated indirectly by transection of the filum terminale: technical case report. Neurosurgery (2011) 0.86
Unruptured intracranial aneurysms: natural history and management decisions. Neurosurg Focus (2004) 0.85
The impact of therapeutic modality on outcomes following repair of ruptured intracranial aneurysms: an administrative data analysis. Clinical article. J Neurosurg (2010) 0.85
Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture. Stroke (2011) 0.85
Safety of intracranial aneurysm surgery performed in a postgraduate training program: implications for training. J Neurosurg (2005) 0.85
Dependence of NMDA/GSK-3β mediated metaplasticity on TRPM2 channels at hippocampal CA3-CA1 synapses. Mol Brain (2011) 0.84
Translating promising preclinical neuroprotective therapies to human stroke trials. Expert Rev Cardiovasc Ther (2011) 0.84
Modulation of NMDAR subunit expression by TRPM2 channels regulates neuronal vulnerability to ischemic cell death. J Neurosci (2013) 0.84
Inhibition of protein kinase C reduces ischemia-induced tyrosine phosphorylation of the N-methyl-d-aspartate receptor. J Neurochem (2003) 0.84
Slow-flow spinal epidural AVF with venous ectasias: two pediatric case reports. AJNR Am J Neuroradiol (2003) 0.83
Intraoperative biplanar rotational angiography during neurovascular surgery. Technical note. J Neurosurg (2009) 0.82
Middle ear aneurysm treated with an innovative, vessel-preserving, aneurysm-occluding stent. Laryngoscope (2010) 0.82